Synthesis of Benzocycloalkanone-Based Michael Acceptors and Biological Activities as Antimalarial and Antitrypanosomal Agents
Molecules · 2023
DOI: 10.3390/molecules28145569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ali Mijoba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 47206, Venezuela. Hauptthemen laut MEDLINE: Antimalarials, Chagas Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Especialidades Espíritu Santo, Escuela de Medicina, Universidad de Especialidades Espíritu Santo (UEES), Ministerio de Ciencia, Tecnología e Innovación de Venezuela.
Abstract (Originalsprache)
A series of benzocycloalkanone derivatives have been prepared and evaluated as antimalarial and antitrypanosomal agents. The compounds were obtained by direct coupling of preformed 4-substituted benzaldehyde and indanone or tetralone substitutes through aldol condensation of Claisen-Schmidt using sodium hydroxide as a catalyst in ethanol at room temperature. Although designed to inhibit the formation of β-hematin in vitro, only three compounds, 10, 11, and 12, showed activities greater than 50% (75.16%, 63.02%, and 56.17%, respectively). The results of the in vivo antimalarial evaluation show that 10, 11, and 12 reduced parasitemia marginally, and an insignificant increase in the days of survival of the mice was observed. As trypanocidals, all compounds showed marginal activity as inhibitors of the proliferation of T. cruzi epimastigotes, except compound 33, with an activity of 51.08 ± 3.4% compared to the activity shown by the reference compound benznidazole 59.99 ± 2.9%. The compounds appear to have little cytotoxic effect against VERO cells in vitro; this new class of Michael acceptor agents clearly warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 47206, Venezuela.
- Laboratory of Parasites Physiology, Biophysics and Biochemistry Center, Instituto Venezolano de Invest Gaciones Científicas, Altos de Pipe 1020-A, Caracas 21827, Venezuela.
- Escuela de Medicina, Universidad Espíritu Santo, Samborondón 092301, Ecuador.
- Departamento de Química, Universidad Técnica Particular de Loja, Loja 1101608, Ecuador.
- Facultad de Ciencias de la Salud y Desarrollo Humano, Univesidad Ecotec, Km. 13.5 Samborondón, Samborondón 092302, Ecuador.
ORCID-Profile: Ali Mijoba, Sandra Espinosa-Tapia, Hegira Ramírez, Jaime E Charris
Förderung
- Universidad de Especialidades Espíritu Santo
- Escuela de Medicina, Universidad de Especialidades Espíritu Santo (UEES)
- Ministerio de Ciencia, Tecnología e Innovación de Venezuela
Zitieren
APA
Mijoba, A., Fernandez-Moreira, E., Parra-Giménez, N., Espinosa-Tapia, S., Blanco, Z., Ramírez, H., & Charris, J. E. (2023). Synthesis of Benzocycloalkanone-Based Michael Acceptors and Biological Activities as Antimalarial and Antitrypanosomal Agents. Molecules. https://doi.org/10.3390/molecules28145569
Vancouver
Mijoba A, Fernandez-Moreira E, Parra-Giménez N, Espinosa-Tapia S, Blanco Z, Ramírez H, et al. Synthesis of Benzocycloalkanone-Based Michael Acceptors and Biological Activities as Antimalarial and Antitrypanosomal Agents. Molecules. 2023. doi:10.3390/molecules28145569
BibTeX
@article{Mijoba2023,
author = {Mijoba, Ali and Fernandez-Moreira, Esteban and Parra-Giménez, Nereida and Espinosa-Tapia, Sandra and Blanco, Zuleyma and Ramírez, Hegira and Charris, Jaime E},
title = {Synthesis of Benzocycloalkanone-Based Michael Acceptors and Biological Activities as Antimalarial and Antitrypanosomal Agents},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28145569}
}
EUVIMED